Daniel Lee Flynn - Jun 16, 2023 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc. (DCPH)

Role
Chief Scientific Officer
Signature
/s/ Jeffrey M. Held, Attorney-in-Fact
Stock symbol
DCPH
Transactions as of
Jun 16, 2023
Transactions value $
-$23,835
Form type
4
Date filed
6/21/2023, 04:05 PM
Previous filing
Feb 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DCPH Common Stock Sale -$23.8K -1.66K -2.81% $14.40 57.2K Jun 16, 2023 Direct F1
holding DCPH Common Stock 181K Jun 16, 2023 By Daniel L. Flynn Revocable Trust F2
holding DCPH Common Stock 91K Jun 16, 2023 By Daniel L. Flynn Irrevocable Trust
holding DCPH Common Stock 49.5K Jun 16, 2023 By GRAT F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was to cover tax liabilities in the vesting of restricted stock units.
F2 Reflects shares previously transferred from the Daniel L. Flynn Revocable Trust to the Reporting Person's grantor retained annuity trust.